Cariprazine (RGH-188), a D3-preferring dopamine D3/D2 receptor partial agonist antipsychotic candidate demonstrates anti-abuse potential in rats

被引:0
|
作者
V. Román
I. Gyertyán
K. Sághy
B. Kiss
Zs. Szombathelyi
机构
[1] Gedeon Richter Plc,Pharmacology and Drug Safety Research
[2] Gedeon Richter Plc.,Department of Behavioural Pharmacology
来源
Psychopharmacology | 2013年 / 226卷
关键词
Cariprazine; Aripiprazole; Bifeprunox; Dopamine receptor; Cocaine self-administration; Cocaine seeking; Relapse; Antipsychotic; Antimanic;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:285 / 293
页数:8
相关论文
共 50 条
  • [31] Binding of the D3-preferring antipsychotic candidate F17464 to dopamine D3 and D2 receptors: a PET study in healthy subjects with [11C]-(+)-PHNO
    Mark Slifstein
    Anissa Abi-Dargham
    Ragy R Girgis
    Raymond F Suckow
    Thomas B Cooper
    Chaitanya R Divgi
    Pierre Sokoloff
    Ludovic Leriche
    Patrick Carberry
    Shunichi Oya
    Simon K Joseph
    Marlène Guiraud
    Agnès Montagne
    Valérie Brunner
    Florence Gaudoux
    Françoise Tonner
    Psychopharmacology, 2020, 237 : 519 - 527
  • [32] Binding of the D3-preferring antipsychotic candidate F17464 to dopamine D3 and D2 receptors: a PET study in healthy subjects with [11C]-(+)-PHNO
    Slifstein, Mark
    Abi-Darghami, Anissa
    Girgis, Ragy R.
    Suckow, Raymond F.
    Coopers, Thomas B.
    Divgi, Chaitanya R.
    Sokoloff, Pierre
    Leriche, Ludovic
    Carberry, Patrick
    Oya, Shunichi
    Joseph, Simon K.
    Guiraud, Marlene
    Montagne, Agnes
    Brunner, Valerie
    Gaudoux, Florence
    Tonner, Francoise
    PSYCHOPHARMACOLOGY, 2020, 237 (02) : 519 - 527
  • [33] Neurochemical and behavioural actions of a novel dopamine D3/D2 receptor antagonist/partial agonist putative antipsychotic
    Kiss, B.
    Gyertyan, I.
    Saghy, K.
    Laszlovszky, I
    Horvath, A.
    Laszy, J.
    Schmidt, E.
    Szabo, Gy
    Againe, Csongor E.
    Adham, N.
    Tihanyi, K.
    Szombathelyi, Zs
    ACTA PHARMACOLOGICA SINICA, 2006, 27 (09) : 1274 - 1275
  • [34] Effects of repeated treatment with the dopamine D2/D3 receptor partial agonist aripiprazole on striatal D2/D3 receptor availability in monkeys
    Paul W. Czoty
    H. Donald Gage
    Pradeep K. Garg
    Sudha Garg
    Michael A. Nader
    Psychopharmacology, 2014, 231 : 613 - 619
  • [35] Cariprazine, A Dopamine D2/D3 Receptor Partial Agonist, Modulates ABCG2-Mediated Multidrug Resistance in Cancer
    Hussein, Noor
    Ashby, Charles R., Jr.
    Amawi, Haneen
    Nyinawabera, Angelique
    Vij, Atul
    Khare, Vishwa M.
    Karthikeyan, Chandrabose
    Tiwari, Amit K.
    CANCERS, 2018, 10 (09)
  • [36] Effects of repeated treatment with the dopamine D2/D3 receptor partial agonist aripiprazole on striatal D2/D3 receptor availability in monkeys
    Czoty, Paul W.
    Gage, H. Donald
    Garg, Pradeep K.
    Garg, Sudha
    Nader, Michael A.
    PSYCHOPHARMACOLOGY, 2014, 231 (03) : 613 - 619
  • [37] Effects of the atypical antipsychotic and D3/D2 dopamine partial agonist cariprazine on effort-based choice behavior: implications for modeling avolition
    Alev Ecevitoglu
    Gayle A. Edelstein
    Rose E. Presby
    Renee A. Rotolo
    Jen-Hau Yang
    Taina Quiles
    Kevin Okifo
    Ryan T. Conrad
    Ashley Kovach
    Merce Correa
    John D. Salamone
    Psychopharmacology, 2023, 240 : 1747 - 1757
  • [38] Effects of the atypical antipsychotic and D3/D2 dopamine partial agonist cariprazine on effort-based choice behavior: implications for modeling avolition
    Ecevitoglu, Alev
    Edelstein, Gayle A.
    Presby, Rose E.
    Rotolo, Renee A.
    Yang, Jen-Hau
    Quiles, Taina
    Okifo, Kevin
    Conrad, Ryan T.
    Kovach, Ashley
    Correa, Merce
    Salamone, John D.
    PSYCHOPHARMACOLOGY, 2023, 240 (08) : 1747 - 1757
  • [39] Aripiprazole: a partial dopamine D2 receptor agonist antipsychotic
    Keck, PE
    McElroy, SL
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2003, 12 (04) : 655 - 662
  • [40] Antidepressant effects of pramipexole, a dopamine D3/D2 receptor agonist, and 7-OH-DPAT, a dopamine D3 receptor agonist, in olfactory bulbectomized rats
    Breuer, Megan E.
    Groenink, Lucianne
    Oosting, Ronald S.
    Buerger, Erich
    Korte, Michiel
    Ferger, Boris
    Olivier, Berend
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2009, 616 (1-3) : 134 - 140